Literature DB >> 22865352

Increased fracture risk assessed by fracture risk assessment tool in Greek patients with Crohn's disease.

Sotirios Terzoudis1, Christos Zavos, John Damilakis, John Neratzoulakis, Daphne Anna Dimitriadi, Maria Roussomoustakaki, Elias A Kouroumalis, Ioannis E Koutroubakis.   

Abstract

BACKGROUND: The World Health Organization has recently developed the fracture risk assessment tool (FRAX) based on clinical risk factors and bone mineral density (BMD) for evaluation of the 10-year probability of a hip or a major osteoporotic fracture. The aim of this study was to evaluate the use of the FRAX tool in Greek patients with inflammatory bowel disease (IBD).
METHODS: FRAX scores were applied to 134 IBD patients [68 Crohn's disease (CD); 66 ulcerative colitis (UC)] who underwent dual-energy X-ray absorptiometry scans at the femoral neck and lumbar spine during the period 2007-2012. Calculation of the FRAX scores, with or without BMD, was made through a web-based probability model used to compute individual fracture probabilities according to specific clinical risk factors.
RESULTS: The median 10-year probability of a major osteoporotic fracture for IBD patients based on clinical data was 7.1%, and including the BMD was 6.2%. A significant overestimation with the first method was found (P = 0.01). Both scores with and without BMD were significantly higher in CD patients compared with UC patients (P = 0.02 and P = 0.005, respectively). The median 10-year probability of hip fracture based on clinical data was 0.8%, and including the BMD was 0.9%. The score with use of BMD was significantly higher in CD compared with UC patients (P = 0.04).
CONCLUSIONS: CD patients have significantly higher FRAX scores and possibly fracture risk compared with UC patients. The clinical FRAX score alone seems to overestimate the risk of osteoporotic fracture in Greek IBD patients.

Entities:  

Mesh:

Year:  2012        PMID: 22865352     DOI: 10.1007/s10620-012-2326-x

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  31 in total

1.  Role of ghrelin and insulin-like growth factor binding protein-3 in the development of osteoporosis in inflammatory bowel disease.

Authors:  Ioannis E Koutroubakis; Christos Zavos; John Damilakis; Georgios Papadakis; John Neratzoulakis; Nikolaos Karkavitsas; Elias A Kouroumalis
Journal:  J Clin Gastroenterol       Date:  2011-07       Impact factor: 3.062

2.  Osteoporosis in patients with inflammatory bowel disease.

Authors:  Charles N Bernstein
Journal:  Clin Gastroenterol Hepatol       Date:  2006-02       Impact factor: 11.382

3.  Femoral neck osteopenia in patients with inflammatory bowel disease.

Authors:  R D Pollak; F Karmeli; R Eliakim; Z Ackerman; K Tabb; D Rachmilewitz
Journal:  Am J Gastroenterol       Date:  1998-09       Impact factor: 10.864

4.  Fracture risk is increased in Crohn's disease, but not in ulcerative colitis.

Authors:  P Vestergaard; K Krogh; L Rejnmark; S Laurberg; L Mosekilde
Journal:  Gut       Date:  2000-02       Impact factor: 23.059

5.  The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications.

Authors:  J Satsangi; M S Silverberg; S Vermeire; J-F Colombel
Journal:  Gut       Date:  2006-06       Impact factor: 23.059

6.  Hip fractures in patients with inflammatory bowel disease and their relationship to corticosteroid use: a population based cohort study.

Authors:  T Card; J West; R Hubbard; R F A Logan
Journal:  Gut       Date:  2004-02       Impact factor: 23.059

Review 7.  Diagnosis of osteoporosis and assessment of fracture risk.

Authors:  John A Kanis
Journal:  Lancet       Date:  2002-06-01       Impact factor: 79.321

8.  Bone mineral density thresholds for pharmacological intervention to prevent fractures.

Authors:  Ethel S Siris; Ya-Ting Chen; Thomas A Abbott; Elizabeth Barrett-Connor; Paul D Miller; Lois E Wehren; Marc L Berger
Journal:  Arch Intern Med       Date:  2004-05-24

9.  FRAX and risk of vertebral fractures: the fracture intervention trial.

Authors:  Meghan G Donaldson; Lisa Palermo; John T Schousboe; Kristine E Ensrud; Marc C Hochberg; Steven R Cummings
Journal:  J Bone Miner Res       Date:  2009-11       Impact factor: 6.741

10.  Low bone mineral density in Greek patients with inflammatory bowel disease: prevalence and risk factors.

Authors:  Ioannis E Koutroubakis; Christos Zavos; John Damilakis; Georgios Z Papadakis; John Neratzoulakis; Nikolaos Karkavitsas; Elias A Kouroumalis
Journal:  Ann Gastroenterol       Date:  2011
View more
  1 in total

1.  A cross-sectional study on nutrient intake and -status in inflammatory bowel disease patients.

Authors:  Jona B Vidarsdottir; Sigridur E Johannsdottir; Inga Thorsdottir; Einar Bjornsson; Alfons Ramel
Journal:  Nutr J       Date:  2016-06-08       Impact factor: 3.271

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.